Medgenics, Inc. Announces Results of 2013 Annual Meeting of Stockholders
5/1/2013 7:35:57 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company” or “Medgenics”),, the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announces that all resolutions proposed at the Company’s Annual Meeting of Stockholders held yesterday were duly passed.
Help employers find you! Check out all the jobs and post your resume.
comments powered by